Tony-nominated lighting designer Isabella Byrd is not afraid of the dark

CCM alum Isabella Byrd received two Tony nominations for her work on Broadway this year

Broadway.com features UC College-Conservatory of Music alumna Isabella Byrd (BFA Lighting Design and Technology, ’09) ahead of the 2024 Tony Awards. Byrd received two Tony Award Nominations — Best Lighting Design of a Play for An Enemy of the People and Best Lighting Design of a Musical for Cabaret at the Kit Kat Club.

"A few years ago, Byrd started calling herself a “darkness designer.” She favors the singular, essential lighting gesture over spectacle for the sake of it, hanging fewer lights than other designers and often coaxing performers out of the shadows with the bare minimum of brightness. She’s into low lighting the way the playwright Annie Baker is fond of pregnant silences.

Her reasons are as aesthetical as they are physiological, based in an understanding of our natural circadian rhythms and night-vision abilities. 'Darkness activates our humanity,' she said. 'If we actually just pull back a little bit, we can see better. We can listen better, we can connect better.' " (via Broadway.com)

Byrd also recently won a special award in the 2024 Drama Desk Awards.

Watch the Tony Awards

The Tony Awards, hosted by Ariana DeBose, will air live on Sunday, June 16, 2024 from the David H. Koch Theater at Lincoln Center for the Performing Arts in New York City. The awards broadcast from 8-11 p.m. ET and 5-8 p.m. PT on the CBS Television Network, and stream live and on demand on Paramount+. Learn more about the Tony Awards.


Featured image at the top: Gayle Rankin and the cast of “Cabaret”. Photo: Marc Brenner.

Additional Contacts

Curt Whitacre | Director of Marketing/Communications | UC College-Conservatory of Music

| 513-556-2683

Related Stories

1

Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy

March 16, 2026

Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.